Most Viewed Articles
| Articles | Fulltext downloads | PDF downloads | Total downloads |
|---|---|---|---|
Review ArticleRole of stem cell transplant in chronic myeloid leukemia in contemporary settingsFull text |  PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_15_2024 |
25,261 | 63,680 | 88,941 |
Case ReportNUTM1-BRD4 fusion mutation-positive salivary gland myoepithelial carcinoma: A diagnostic conundrumFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_2_2025 |
19,687 | 62,572 | 82,259 |
Case ReportGastric cancer or hodgkin lymphoma? Unraveling the diagnostic dilemma of primary gastric classical hodgkin lymphomaFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_28_2024 |
21,724 | 59,087 | 80,811 |
Case ReportCase report – Muir–Torre syndrome – A skin-deep manifestation of underlying malignancyFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_26_2024 |
14,853 | 65,251 | 80,104 |
Cardio Oncology with ACOSImmune checkpoint inhibitor-induced acute fulminant myocarditis: A case report and review of literatureFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_33_2024 |
21,214 | 57,812 | 79,026 |
Review ArticleAntibody-drug conjugate review in breast cancer: A targeted approachFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_30_2024 |
16,989 | 46,744 | 63,733 |
Short CommunicationOutcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in BangladeshFull text | PDF Volume 6 | Issue 1 | January-April 2021DOI: 10.25259/IJMIO_30_2020 |
57,029 | 5,523 | 62,552 |
Case ReportBreast carcinoma disguised as systemic sclerosis: A case report of unusual paraneoplastic syndromeFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_4_2024 |
20,060 | 40,142 | 60,202 |
Short CommunicationDriver mutations in oncogenesisFull text | PDF Volume 6 | Issue 2 | May-August 2021DOI: 10.25259/IJMIO_26_2020 |
49,566 | 8,210 | 57,776 |
Review ArticleGenetic diversity and variation in chronic myeloid leukemia patients of Indian origin- Implications for treatment response and prognosisFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_11_2024 |
15,082 | 38,221 | 53,303 |
Review ArticleEmerging strategies in cancer immunotherapy: Expanding horizons and future perspectivesFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_24_2024 |
24,403 | 25,957 | 50,360 |
Review ArticleEmerging role of immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell carcinomaFull text | PDF Volume 10 | Issue 3 | September-December 2025DOI: 10.25259/IJMIO_22_2025 |
14,853 | 33,224 | 48,077 |
Case ReportNivolumab-induced vitiligo in a patient treated for metastatic melanomaFull text | PDF Volume 10 | Issue 2 | May-August 2025DOI: 10.25259/IJMIO_10_2025 |
11,062 | 34,327 | 45,389 |
Case ReportReal life experience of complete remission with modified MEMMAT regimen with LACE induction followed by ASCT as consolidation in Recurrent Medulloblastoma -A case reportFull text | PDF Volume 10 | Issue 2 | May-August 2025DOI: 10.25259/IJMIO_31_2024 |
10,835 | 33,681 | 44,516 |
Case SeriesReal-world experience of chronomodulated prescription of cyclin-dependent kinases 4/6 inhibitor palbociclib in reducing hematological toxicity – A case seriesFull text | PDF Volume 10 | Issue 2 | May-August 2025DOI: 10.25259/IJMIO_34_2024 |
10,426 | 33,565 | 43,991 |
Review ArticleMini review: Molecular pathology of personalized medicine in cancer susceptibility syndromesFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_12_2023 |
30,480 | 4,800 | 35,280 |
Original ArticleSpectrum of lymphomas in IndiaFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_18_2023 |
27,833 | 6,401 | 34,234 |
Original ArticleOutcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from IndiaFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_15_2023 |
29,223 | 4,591 | 33,814 |
EditorialChallenging conventional wisdom in molecular oncology: New perspectivesFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_20_2023 |
28,437 | 4,654 | 33,091 |
Case ReportLong-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in IndiaFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_16_2023 |
27,021 | 4,678 | 31,699 |
Review ArticleIs continuous infusion of high-dose ifosfamide, a safe option? Drug reviewFull text | PDF Volume 5 | Issue 2 | May-August 2020DOI: 10.25259/IJMIO_21_2019 |
21,968 | 9,694 | 31,662 |
Review ArticleMolecular oncology and the role of artificial intelligence in advancing cancer treatmentFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_17_2023 |
24,709 | 3,669 | 28,378 |
Case ReportClinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemiaFull text | PDF Volume 7 | Issue 2 | May – August 2022DOI: 10.25259/IJMIO_5_2022 |
18,025 | 9,987 | 28,012 |
Review ArticleRedefining treatment-free remission criteria in chronic myeloid leukemia in IndiaFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_10_2024 |
24,604 | 3,014 | 27,618 |
Review ArticleMolecular genetics changes in gallbladder carcinomaFull text | PDF Volume 5 | Issue 2 | May-August 2020DOI: 10.25259/IJMIO_19_2019 |
17,073 | 9,708 | 26,781 |
Case ReportSquamous cell carcinoma of lung presenting as “Sunray sign” in chest radiographFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_6_2023 |
20,655 | 5,948 | 26,603 |
Review ArticleHigh-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspectiveFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_1_2024 |
20,879 | 5,259 | 26,138 |
EditorialCrucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancerFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_2_2024 |
19,560 | 6,126 | 25,686 |
Review ArticleUse of five-day chronomodulated prescription of palbociclib as myelopreservation drug along with Topotecan in recurrent extensive stage small cell lung carcinoma – A perspective articleFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_3_2024 |
20,065 | 5,420 | 25,485 |
Review ArticlePatient perspectives on living with chronic myeloid leukemia in India: Quality of life, psychosocial support, and stigmaFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_17_2024 |
20,939 | 4,517 | 25,456 |
Review ArticleCan CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teachingFull text | PDF Volume 7 | Issue 2 | May – August 2022DOI: 10.25259/IJMIO_8_2022 |
16,675 | 8,264 | 24,939 |
Review ArticleUnderstanding immunotherapy and CAR-T-cells: A narrative reviewFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_22_2023 |
20,270 | 4,603 | 24,873 |
NewsEditorial board tribute to Dr. Amit VermaFull text | PDF Volume 6 | Issue 3 | September-December 2021 |
18,390 | 5,834 | 24,224 |
Brief CommentaryBioactive lipid: A novel diagnostic approach for retinoblastoma in clinical managementFull text | PDF Volume 6 | Issue 3 | September-December 2021DOI: 10.25259/IJMIO_7_2021 |
16,335 | 6,929 | 23,264 |
Cardio Oncology with ACOSIbrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survivalFull text | PDF Volume 7 | Issue 2 | May – August 2022DOI: 10.25259/IJMIO_1_2022 |
14,963 | 7,262 | 22,225 |
Case ReportComplete metabolic response with letrozole and palbociclib in advanced breast cancerFull text | PDF Volume 4 | Issue 3 | September-December 2019DOI: 10.25259/IJMIO_2_2019 |
13,438 | 8,699 | 22,137 |
Review ArticleSignaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targetsFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_29_2022 |
16,985 | 4,594 | 21,579 |
Review ArticleGenomic profiling of retinoblastoma using aqueous humor liquid biopsy – A rapid reviewFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_25_2024 |
20,377 | 990 | 21,367 |
Case ReportL1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case reportFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_11_2023 |
16,832 | 4,466 | 21,298 |
Review ArticleImmune dynamics of SARS-CoV-2 virus evolutionFull text | PDF Volume 7 | Issue 1 | January-April 2022DOI: 10.25259/IJMIO_26_2021 |
13,680 | 7,521 | 21,201 |
Original ArticlePrevalence of germline mutations in women with breast and/or ovarian cancer in a tertiary care center in Pune, IndiaFull text | PDF Volume 8 | Issue 2 | May-August 2023DOI: 10.25259/IJMIO_5_2023 |
16,208 | 4,947 | 21,155 |
Review ArticlePost-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspectiveFull text | PDF Volume 6 | Issue 3 | September-December 2021DOI: 10.25259/IJMIO_12_2021 |
15,749 | 5,387 | 21,136 |
Review ArticleThe Cancer Genomic Atlas – “TO CONQUER CANCER”Full text | PDF Volume 6 | Issue 2 | May-August 2021DOI: 10.25259/IJMIO_28_2020 |
13,928 | 7,068 | 20,996 |
Case ReportHyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young maleFull text | PDF Volume 6 | Issue 3 | September-December 2021DOI: 10.25259/IJMIO_16_2021 |
16,404 | 4,587 | 20,991 |
Original ArticleIncorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change?Full text | PDF Volume 7 | Issue 2 | May – August 2022DOI: 10.25259/IJMIO_2_2022 |
13,967 | 6,689 | 20,656 |
Brief CommentaryBreast cancer prognostic tools: A promising Indian optionFull text | PDF Volume 5 | Issue 2 | May-August 2020DOI: 10.25259/IJMIO_15_2020 |
13,091 | 7,555 | 20,646 |
Review ArticlePotential therapeutic molecular targets for better outcomes for patients with lung cancerFull text | PDF Volume 8 | Issue 2 | May-August 2023DOI: 10.25259/IJMIO_27_2022 |
17,512 | 3,075 | 20,587 |
Review ArticleAdvances in immunotherapy for metastatic esophageal cancerFull text | PDF Volume 7 | Issue 3 | September-December 2022DOI: 10.25259/IJMIO_14_2022 |
13,357 | 7,163 | 20,520 |
Review ArticleA compendium of population wide DNA methylation profile for oral cancer in IndiaFull text | PDF Volume 6 | Issue 2 | May-August 2021DOI: 10.25259/IJMIO_2_2021 |
13,456 | 6,828 | 20,284 |
New Drug UpdateAmlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitorFull text | PDF Volume 6 | Issue 3 | September-December 2021DOI: 10.25259/IJMIO_13_2021 |
16,267 | 3,999 | 20,266 |